Abstract
As the Edmond J. Safra Center for Ethics has developed its lens for studying institutional corruption, it has focused on the need for researchers to identify the “improper dependencies”—or, alternatively described, the “economies of influence”—that may have proven corrupting to the institution. In the previous chapter, we looked at how, with the publication of DSM-III, a potential conflict arose between the APA’s guild interests and its ethical obligations as a medical discipline. The APA had a guild interest in promoting its new disease model, and yet, at the same time, it had an ethical obligation to inform the public, in a thorough and balanced way, what research was revealing about the nature of psychiatric disorders and the drugs used to treat them. In this chapter, we begin our inquiry into the conduct of the APA and organized psychiatry since that seminal moment in 1980, and, as a first step, it is necessary to detail the rise and growth of “economies of influence” that may have shaped psychiatry’s behavior during the past 35 years. In this way, it is possible to see the financial influences that have been present during this period, and may have affected psychiatry’s conduct.
Dependence upon funders produces a subtle, understated, camouflaged bending to keep the funders happy … they become in the words of the X Files, “shape shifters” as they constantly adjust their views.
—Lawrence Lessig, 20131
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
L. Lessig. “We the People, and the Republic We Must Reclaim.” TED talk, February 2013.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 137 (1980): 1308–12.
L. Havens. “Twentieth-century psychiatry.” Am J Psychiatry 138 (1981): 1279–87.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 138 (1981): 1418–21.
W. Sorum. “Report of the speaker.” Am J Psychiatry 140 (1983): 1403–4.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 139 (1982): 1392–6.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 140 (1983): 1397–1403.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 143 (1986): 1342–6.
S. Frazier. “Report of the secretary, summary of meetings of Board of Trustees, May 1983–1984.” Am J Psychiatry 141 (1984): 1314–21.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 142 (1985): 1243–6; and Sabshin, 1986, ibid.
M. Sabshin. Changing American Psychiatry (Washington, DC: American Psychiatric Publishing, 2008): 78.
M. Sabshin. “Report of the medical director.” Am J Psychiatry, 147 (1990): 1411–17.
E. Benedek. “Report of the secretary: summary of actions of the Board of Trustees, May 1986–May 1987.” Am J Psychiatry 144 (1987): 1381–8.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 144 (1987): 1390–3.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 149 (1992): 1434–44.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 150 (1993): 1591–601.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 151 (1994): 1546–56.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 148 (1991): 1444–50.
M. Riba. “Presidential Address.” Am J Psychiatry 162 (2005): 2040–4.
J. Borenstein. “The council on communications.” Am J Psychiatry 167 (2010): 228.
A cited by P. Breggin, Toxic Psychiatry (New York: St. Martin’s Press, 1991): 354.
G. Pollock. “Report of the treasurer.” Am J Psychiatry 138 (1981): 1415–17.
F. Gottlieb. “Report of the speaker.” Am J Psychiatry 142 (1985): 1248.
Psychiatric News, April 3, 1987; as cited by P. Breggin, Toxic Psychiatry (New York: St. Martin’s Press, 1991): 347.
E. Benedek. “Report of the secretary.” Am J Psychiatry 144 (1987): 1381–8; and Am J Psychiatry 145 (1988): 1328–36.
M. Sabshin. “Report of the medical director.” Am J Psychiatry 145 (1988): 1340–2.
N. Rao. “The council on medical education and career development.” Am J Psychiatry 158 (2001): 342–3;
J. Greden. “The council on research.” Am J Psychiatry 158 (2001): 346–8;
J. Scully. “Report of the medical director.” Am J Psychiatry 161 (2004): 1735–6.
C. Bernstein. “Report of the treasurer.” Am J Psychiatry 158 (2001): 1760–1. For percentages in 2006 and 2008, see APA report. “Pharmaceutical Revenue 2010,” which provided the amounts received from pharmaceutical companies from 2006 to 2010.
C. Bernstein. “Report of the treasurer.” Am J Psychiatry 159 (2002): 1622.
F. Gottlieb. “Report of the speaker.” Am J Psychiatry 142 (1985): 1246–9.
M. Dumont. “In bed together at the market: psychiatry and the pharmaceutical industry.” Am J Orthopsychiatry 60 (1990): 484–5.
E. Silverman. “Grassley probes psychiatrists over ties to pharma.” Pharmalot.comv, July 11, 2008.
A. Schatzberg, APA Presidential Address, Am J Psychiatry 167 (2010): 1161–5.
L. Cosgrove. “Financial ties between DSM-IV panel members and the pharmaceutical industry.” Psychother Psychosom 75 (2006): 154–60.
L. Cosgrove. “Conflicts of interest and disclosure in the American Psychiatric Association’s clinical practice guidelines.” Psychother Psychosom 78 (2009): 228–32.
G. Fava. “Should the drug industry work with key opinion leaders? No.” BMJ 336 (2008): 1405.
Copyright information
© 2015 Robert Whitaker and Lisa Cosgrove
About this chapter
Cite this chapter
Whitaker, R., Cosgrove, L. (2015). Economies of Influence. In: Psychiatry Under the Influence. Palgrave Macmillan, New York. https://doi.org/10.1057/9781137516022_3
Download citation
DOI: https://doi.org/10.1057/9781137516022_3
Publisher Name: Palgrave Macmillan, New York
Print ISBN: 978-1-349-50598-2
Online ISBN: 978-1-137-51602-2
eBook Packages: Palgrave Social Sciences CollectionSocial Sciences (R0)